Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Radiofrequency ablation Stories

2010-09-08 09:23:00

ST. LOUIS, Sept. 8 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) highlighted significant new additions to the body of evidence demonstrating exceptional clinical outcomes achieved with its Niobe® Magnetic Navigation System in ventricular tachycardia (VT) ablation. At the European Cardiology Society Annual Congress in Stockholm last week, the research team led by Dr. Tamas Szili-Torok from the Erasmus Medical Center in Rotterdam presented the first...

2010-09-07 07:00:00

SUNNYVALE, Calif., Sept. 7 /PRNewswire/ -- BARRX Medical, Inc., a world leader in endoscopic treatment solutions for treating precancerous lesions of the esophagus as well as other chronic gastrointestinal diseases, announced today that the company has signed an exclusive agreement with Medico's Hirata for distribution of the HALO Radiofrequency Ablation System in Japan. Japan has one of the highest concentrations of esophageal squamous cell cancers in the world. Traditionally treated by...

2010-08-31 11:11:00

AUSTIN, Texas, Aug. 31 /PRNewswire/ -- Atrial Fibrillation (A Fib) -- a type of heart rhythm disorder that affects the electrical system, or "wiring," of the heart muscle -- is often referred to as the "silent killer," and can suddenly trigger a massive, debilitating stroke or even death. During September -- National Atrial Fibrillation Awareness Month -- physicians at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center are working to raise awareness about...

2010-08-26 16:58:44

August JVIR supplement offers review of outcomes, state-of-the-art devices and uses to medically kill cancer The unprecedented growth and promise of using thermal ablation to target and kill cancer is the subject of the Journal of Vascular and Interventional Radiology's August supplement, "Thermal Ablation 2010: At the Crossroads of Past Success, Current Goals and Future Technology." "The Journal of Vascular and Interventional Radiology supplement sheds light on the development of multiple...

2010-07-08 03:59:00

WATERLOO, Belgium, July 8, 2010 /PRNewswire/ -- Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announces that more than 10 patients have now been enrolled in the CLARITY-study ("CLARITY-AF"), comparing the efficacy, safety and efficiency of CARTO(R) 3 System guided radiofrequency ablation using the NAVISTAR(R) THERMOCOOL(R) catheter versus fluoroscopy guided radiofrequency ablation using the Pulmonary Vein Ablation catheter(R) (PVAC(R),...

2010-06-28 07:00:00

SUNNYVALE, Calif., June 28 /PRNewswire/ -- BARRX Medical Inc., a world leader in products to treat pre-cancerous tissue in the esophagus, reported today that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has published new guidelines approving the use of radiofrequency ablation for the eradication of dysplastic Barrett's esophagus. Barrett's esophagus is a precancerous condition that affects over 6.6 million people around the world and is caused by...

2010-06-15 19:00:00

LIVERMORE, Calif., June 15 /PRNewswire/ -- Halt Medical, Inc., today announced that the U.S. Food and Drug Administration (FDA) has cleared the Halt 2000GI(TM) Electrosurgical System for soft tissue ablation using radiofrequency energy. "This clearance to market is a major milestone for our customers, employees and investors," said Russ DeLonzor, President and Chief Operating Officer. Radiofrequency Ablation (RFA) with the Halt System is a very precise, minimally invasive procedure...

2010-06-14 06:30:00

CLEVELAND, June 14 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that medical technology company Endosense has awarded DATATRAK the first two studies in the EFFICAS study series. The EFFICAS studies are intended to demonstrate that the use of contact force control during cardiac ablation utilizing Endosense's TactiCath®...

2010-06-08 06:45:00

CRM, Electrophysiology and Ablation Market to Reach Over $12 Billion VANCOUVER, June 8 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device and pharmaceutical market research, the U.S. cardiac rhythm management (CRM), electrophysiology and ablation device market is estimated at $8.1 billion with expected growth to over $12 billion by 2016. Increased incidence of cardiac disease and improved diagnostic technology...

2010-06-02 20:33:07

A minimally invasive technique used to destroy kidney tumors with an electrically controlled heating probe showed similar effectiveness as surgical removal of tumors in curbing cancer recurrence rates for up to five years after treatment. In an article available online in the journal Cancer, Dr. Jeffrey Cadeddu, professor of urology and radiology at UT Southwestern Medical Center, reported the outcomes of more than 200 patients who were treated with radiofrequency ablation (RFA). Once the...